山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (1): 94-96.doi: 10.6040/j.issn.1671-7554.0.2015.693
• 临床医学 • 上一篇
徐志宏1,姚铁柱2,吴小华3
中图分类号:
| [1] Koyama T, Mikami Y, Saga T, et al. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation[J]. Abdom Imaging, 2007, 32(6):784-795. [2] Chen S, Paruligiani G. Meta—analysis of BRCAl and BRCA2 penetrance[J]. J Clin Oneol, 2007, 25(11):1329-1333. [3] Vollebergh MA, Lips EH, Nederlof PM, et al. Genomic patterns resembling BRCAl-and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy[J]. Breast Cancer Res, 2014, 16(3):R47. [4] Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCAl or BRCA2 mutations detected in case series unselected for family history: a combined analysis of22 studies[J]. Am J Hum Genet, 2003, 72(5):1117- 1130. [5] 李向东.C-erbB-2、ER和PR在乳腺癌中的表达与预后意义[J].现代肿瘤医学,2006,14(3):289. LI Xiangdong. Expression and prognostic significance of C-erbB-2, ER and PR in breast cancer[J]. Modern Oncology Medicine, 2006, 14(3):289. [6] Verma S, Joy AA, Rayson D, et al. HER story: the next chapter in HER-2-directed therapy for advanced breast cancer[J]. Oncologist, 2013, 18(11):1153-1166. [7] Giordano SH, Temin S, Kirshner JJ, et al. Systemic therapy for patients with advanced human epidermal growth factor receptor2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline[J]. J Clin Oncol, 2014, 32(19):2078-2099. [8] Verri E, Guglielmini P, Puntoni M, et al. NER2/neu oncoprotein overexpression in epitheliaI ovarian cancer: evaluation of its prevalence and prognosticsignificance[J]. Oncology, 2005, 68:154-161. [9] 何以丰,徐丛剑,冯令达.HER2与上皮性卵巢癌术后生存率相关性的Meta分析[J].中国循证医学杂志,2007,7(6):420. HE Yifeng, XU Congjian, FENG Lingda. Meta analysis of the correlation between HER2 and the survival rate of epithelial ovarian cancer[J]. Chinese Journal of Evidence-based Medicine, 2007, 7(6):420. [10] Camilleri-Broet S, Hardy-Bessard AC, Le Tourneau A, et al. HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group[J]. Ann Oncol, 2004, 15(1):104. [11] Riener EK, Arnold N, Kommoss F, et al. The prognostic and predictive valw of immunohistochemically detected,Her-2 overexpression in 361 patients with ovarian cancer;a multicenter study[J]. Gynecol Oncol, 2004, 95(1):89. [12] Wolff EF, Martel M, Gwin K, et al. Synchronous primary breast and ovarian cancer with ovarian cancer metastases to a breast sentinel lymph node[J]. Breast J, 2009, 15(2):203-205. [13] Sandor V, Reed E, Sarosy G, et al. Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease—free survival[J]. Ann Oncol, 1999, 10(5): 585-588. [14] Lesnock JL, Darcy KM, Tian C, et al. BRCAl expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a gynecologic oncology group study[J]. Br J Cancer, 2013, 108(6):1231-1237. |
| [1] | 古春青,郭睿思,周勤勤,刘恒辉,巴婉玉,孙士玲,王冰,郑玉玲,吴宿慧. 基于网络药理学和动物实验探讨酸枣仁-远志药对治疗乳腺癌相关性失眠的作用机制[J]. 山东大学学报 (医学版), 2026, 64(1): 99-108. |
| [2] | 刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74. |
| [3] | 王雪梅,杨豪,宋洋,程世超,张婷婷,王艳春. 抗糖尿病药物与女性恶性肿瘤的因果关联:一项两样本孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(6): 67-77. |
| [4] | 余之刚,郑超. 乳腺癌多学科诊疗的现状、挑战与创新模式[J]. 山东大学学报 (医学版), 2025, 63(1): 1-9. |
| [5] | 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16. |
| [6] | 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24. |
| [7] | 王敏, 李习平, 檀军, 邱梅, 侯泽宇, 田莹, 罗鸿莹, 范超文, 齐玲, 俞琦, 谢薇. 慢病毒载体介导Gag-Caspase-8诱导三阴性乳腺癌原代细胞凋亡及S期阻滞[J]. 山东大学学报 (医学版), 2025, 63(1): 25-34. |
| [8] | 张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42. |
| [9] | 宋雅雯,郭联涛,孔德光,孙圣荣. VTCN1导致HR+乳腺癌预后不良及内分泌治疗耐药[J]. 山东大学学报 (医学版), 2025, 63(1): 43-59. |
| [10] | 刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72. |
| [11] | 孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80. |
| [12] | 李永,崔书君,杨飞,张凡,殷晓霞. 基于增强MRI的亚区域影像组学模型可预测乳腺癌患者新辅助化疗后的病理完全反应[J]. 山东大学学报 (医学版), 2025, 63(1): 81-89. |
| [13] | 袁宗怀,潘广晔,迟曰梅,安传国,张永刚. 孟德尔随机化分析低级别浆液性卵巢癌与乳腺癌的因果关系[J]. 山东大学学报 (医学版), 2025, 63(1): 99-107. |
| [14] | 艾宪程,王斐,周文重,于理想,周飞,相玉娟,李亮,余之刚. 山东省38所三甲医院乳腺多学科诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(1): 108-114. |
| [15] | 王潇晗,吴学君,董典宁,王茂华,韩宗霖,高培显,孔祥骞. 原发性主动脉血栓形成诊治单中心经验[J]. 山东大学学报 (医学版), 2024, 62(9): 115-124. |
|
||
